Advancing Cancer Immunotherapy with Anti-CCR8 Antibodies

agregó una foto Health

2025-11-17 17:56:02

Emergence and Importance of Anti-CCR8 Antibodies Anti-CCR8 antibodies have gained attention as a novel class of immunotherapies aimed at enhancing anti-tumor immunity by targeting regulatory T cells (Tregs) within the tumor microenvironment. These antibodies act on the CCR8 chemokine receptor, highly expressed on tumor-infiltrating Tregs that suppress immune responses and facilitate cancer...

0 Commentarios 0 Acciones 59 Views 0 Vista previa